goodrx helps americans save on prescriptions. americans spend over $400 billion a year on prescriptions, and too many people simply can't find affordable prescriptions. even if you have insurance or medicare. we offer a website and mobile apps that gathers current prices, powerful savings tips and valuable discounts for every prescription drug at virtually every pharmacy in the us. goodrx is used by thousands of physicians and millions of americans each month. we have saved americans over $3 billion. we're not going to rest until prescriptions are affordable for all americans. we also offer goodrx for benefits, which provides technology solutions for health plans, payors and pbm's in an easy-to-understand website and mobile app experience. learn more at www.goodrx.com/benefits.
Company profile
Ticker
GDRX
Exchange
Website
CEO
Doug Hirsch
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
SEC CIK
Corporate docs
Subsidiaries
GoodRx Intermediate Holdings, LLC • GoodRx, Inc. • Iodine, Inc. • GoodRx Care, LLC • Lighthouse Acquisition Corp. • Scriptcycle, LLC • HealthiNation Inc. • RxSaver, Inc. • Buckeye Acquisition, LLC • flipMD, Inc. ...
IRS number
475104396
GDRX stock data
Latest filings (excl ownership)
10-Q
2024 Q1
Quarterly report
9 May 24
8-K
Goodrx Reports First Quarter 2024 Results
9 May 24
EFFECT
Notice of effectiveness
3 May 24
ARS
2023 FY
Annual report to shareholders
25 Apr 24
DEFA14A
Additional proxy soliciting materials
25 Apr 24
DEF 14A
Definitive proxy
25 Apr 24
S-3
Shelf registration
5 Apr 24
8-K
Company Announces Board Resignations
14 Mar 24
8-K
Departure of Directors or Certain Officers
7 Mar 24
8-K
Other Events
7 Mar 24
Transcripts
GDRX
Earnings call transcript
2024 Q1
9 May 24
GDRX
Earnings call transcript
2023 Q4
29 Feb 24
GDRX
Earnings call transcript
2023 Q3
9 Nov 23
GDRX
Earnings call transcript
2023 Q2
9 Aug 23
GDRX
Earnings call transcript
2023 Q2
9 Aug 23
GDRX
Earnings call transcript
2023 Q1
10 May 23
GDRX
Earnings call transcript
2022 Q4
28 Feb 23
GDRX
Earnings call transcript
2022 Q3
9 Nov 22
GDRX
Earnings call transcript
2022 Q2
8 Aug 22
GDRX
Earnings call transcript
2022 Q1
9 May 22
Latest ownership filings
Financial summary
Quarter (USD) | Mar 24 | Dec 23 | Sep 23 | Jun 23 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 533.30 mm | 533.30 mm | 533.30 mm | 533.30 mm | 533.30 mm | 533.30 mm |
Cash burn (monthly) | 46.33 mm | 18.98 mm | (no burn) | 3.80 mm | (no burn) | (no burn) |
Cash used (since last report) | 73.70 mm | 30.19 mm | n/a | 6.04 mm | n/a | n/a |
Cash remaining | 459.60 mm | 503.10 mm | n/a | 527.26 mm | n/a | n/a |
Runway (months of cash) | 9.9 | 26.5 | n/a | 138.9 | n/a | n/a |
Institutional ownership, Q4 2023
13F holders | Current |
---|---|
Total holders | 32 |
Opened positions | 3 |
Closed positions | 132 |
Increased positions | 5 |
Reduced positions | 8 |
13F shares | Current |
---|---|
Total value | 13.96 bn |
Total shares | 184.68 mm |
Total puts | 3.90 k |
Total calls | 8.50 k |
Total put/call ratio | 0.5 |
Largest owners | Shares | Value |
---|---|---|
Francisco Partners Iv | 84.70 mm | $2.53 bn |
Idea Men | 50.16 mm | $0.00 |
Spectrum Equity VII | 36.15 mm | $208.20 mm |
The Hirsch Family Irrevocable Trust | 3.12 mm | $101.96 mm |
Bezdek Family Irrevocable Trust | 3.12 mm | $101.96 mm |
Goldman Sachs & Co | 2.60 mm | $104.77 mm |
Abdiel Qualified Master Fund | 2.59 mm | $40.38 mm |
Assenagon Asset Management | 1.35 mm | $9.04 bn |
Millennium Management | 602.93 k | $0.00 |
Mirae Asset Global Investments | 112.68 k | $754.94 mm |
Recent insider trades
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
8 May 24 | Romin Nabiey | Class A Common Stock | Payment of exercise | Dispose F | No | No | 7.53 | 4,518 | 34.02 k | 125,817 |
8 May 24 | Romin Nabiey | Class A Common Stock | Option exercise | Acquire M | No | No | 0 | 12,662 | 0.00 | 130,335 |
8 May 24 | Romin Nabiey | RSU Class A Common Stock | Option exercise | Dispose M | No | No | 0 | 12,662 | 0.00 | 151,953 |
8 May 24 | Scott Wagner | Class A Common Stock | Payment of exercise | Dispose F | No | No | 7.53 | 25,188 | 189.67 k | 45,404 |
8 May 24 | Scott Wagner | Class A Common Stock | Option exercise | Acquire M | No | No | 0 | 70,592 | 0.00 | 70,592 |
8 May 24 | Scott Wagner | RSU Class A Common Stock | Option exercise | Dispose M | No | No | 0 | 70,592 | 0.00 | 494,140 |
15 Apr 24 | Romin Nabiey | Class A Common Stock | Payment of exercise | Dispose F | No | No | 6.83 | 930 | 6.35 k | 117,673 |
15 Apr 24 | Romin Nabiey | Class A Common Stock | Option exercise | Acquire M | No | No | 0 | 2,606 | 0.00 | 118,603 |
15 Apr 24 | Romin Nabiey | RSU Class A Common Stock | Option exercise | Dispose M | No | No | 0 | 2,606 | 0.00 | 7,818 |
16 Mar 24 | Scott Wagner | Stock Option Class A Common Stock | Grant | Acquire A | No | No | 6.91 | 908,739 | 6.28 mm | 908,739 |
News
Raymond James Upgrades GoodRx Holdings to Outperform, Announces $10 Price Target
16 May 24
Forecasting The Future: 13 Analyst Projections For GoodRx Holdings
16 May 24
TD Cowen Maintains Buy on GoodRx Holdings, Raises Price Target to $16
16 May 24
GoodRx Shares Soar Nearly 10% As New Partnership With Kroger Promises Big Savings
15 May 24
NEXTracker Posts Upbeat Earnings, Joins monday.com, Nu Holdings And Other Big Stocks Moving Higher On Wednesday
15 May 24
Press releases
GoodRx Holdings, Inc. (GDRX) Investors: June 21, 2024 Filing Deadline in Securities Class Action - Contact Kessler Topaz Meltzer & Check, LLP
18 May 24
Levi & Korsinsky Notifies Shareholders of GoodRx Holdings, Inc.(GDRX) of a Class Action Lawsuit and an Upcoming Deadline
17 May 24
DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of GoodRx
17 May 24
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Sharecare, Rivian, GoodRx, and Autodesk and Encourages Investors to Contact the Firm
16 May 24
SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against GoodRx Holdings, Inc. - GDRX
16 May 24